ES and iPS cell research for cardiovascular regeneration

Experimental Cell Research

Volumn 316, Issue 16, 2010, Pages 2555-2559

  Yamashita, Jun K ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Blood vessel; Drug discovery; Heart; Induced pluripotent stem cells; Regeneration

Indexed keywords

ASCORBIC ACID; CARDIAC AGENT; CARDIOGENOL; CYCLOSPORIN A; HYDRAZONE DERIVATIVE; SULFONYLHYDRAZONE; UNCLASSIFIED DRUG;

BIOSAFETY; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; DRUG RESEARCH; EMBRYONIC STEM CELL; EPIGENETICS; HEART MUSCLE CELL; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; ADULT; CARDIOVASCULAR SYSTEM; CYTOLOGY; MEDICAL RESEARCH; PATHOPHYSIOLOGY; REGENERATIVE MEDICINE;

IPS;

ADULT; BIOMEDICAL RESEARCH; CARDIOVASCULAR SYSTEM; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MYOCYTES, CARDIAC; REGENERATIVE MEDICINE;

EID: 77955844034     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.04.004     Document Type: Review

References (36)

1. Gonzales C., Pedrazzini T. Progenitor cell therapy for heart disease. Exp. Cell Res. 2009, 315:3077-3085.
2. Yamashita J., Itoh H., Hirashima M., Ogawa M., Nishikawa S., Yurugi T., Naito M., Nakao K., Nishikawa S.I. Flk1 positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000, 408:92-96.
3. Yamashita J.K., Takano M., Hiraoka-Kanie M., Shimazu C., Yan P., Yanagi K., Nakano A., Inoue E., Kita F., Nishikawa S.I. Prospective identification of cardiac progenitor potentials by a novel single cell-based cardiomyocyte induction. FASEB J. 2005, 19:1534-1536.
4. Narazaki G., Uosaki H., Teranishi M., Okita K., Kim B., Matsuoka S., Yamanaka S., Yamashita J.K. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 2008, 118:498-506.
5. Yamashita J.K. Differentiation and diversification of vascular cells from ES cells. Int. J. Hematol. 2004, 80:1-6.
6. Nishikawa S.I., Nishikawa S., Hirashima M., Matsuyoshi N., Kodama H. Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages. Development 1998, 125:1747-1757.
7. Kataoka H., Takakura N., Nishikawa S., Tsuchida K., Kodama H., Kunisada T., Risau W., Kita T., Nishikawa S.I. Expressions of PDGF receptor alpha, c-Kit and Flk1 genes clustering in mouse chromosome 5 define distinct subsets of nascent mesodermal cells. Dev. Growth Differ. 1997, 39:729-740.
8. Shalaby F., Ho J., Stanford W.L., Fischer K.D., Schuh A.C., Schwartz L., Bernstein A., Rossant J. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 1997, 89:981-990.
9. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380:435-439.
10. Yamashita J.K. Differentiation of arterial, venous, and lymphatic endothelial cells from vascular progenitors. Trends Cardiovasc. Med. 2007, 17:59-63.
11. Hirashima M., Kataoka H., Nishikawa S., Matsuyoshi N., Nishikawa S. Maturation of embryonic stem cells into endothelial cells in an in vitro model of vasculogenesis. Blood 1999, 93:1253-1263.
12. Yurugi-Kobayashi T., Itoh H., Schroeder T., Nakano A., Narazaki G., Kita F., Yanagi K., Hiraoka-Kanie M., Inoue E., Ara T., Nagasawa T., Just U., Nakao K., Nishikawa S.I., Yamashita J.K. Adrenomedullin/cyclic AMP pathway induces Notch activation and differentiation of arterial endothelial cells from vascular progenitors. Arterioscler. Thromb. Vasc. Biol. 2006, 26:1977-1984.
13. Kono T., Kubo H., Shimazu C., Ueda Y., Takahashi M., Yanagi K., Fujita F., Tsuruo T., Wada H., Yamashita J.K. Differentiation of lymphatic endothelial cells from embryonic stem cells on OP9 stromal cells. Arterioscler. Thromb. Vasc. Biol. 2006, 26:2070-2076.
14. Kodama H., Nose M., Niida S., Nishikawa S., Nishikawa S. Involvement of the c-kit receptor in the adhesion of hematopoietic stem cells to stroma cells. Exp. Hematol. 1992, 2:979-984.
15. Yamamizu K., Kawasaki K., Katayama S., Watabe T., Yamashita J.K. Enhancement of vascular progenitor potential by protein kinase A through dual induction of Flk-1 and Neuropilin-1. Blood 2009, 114:3707-3716.
16. Yamamizu K., Matsunaga T., Uosaki H., Katayama S., Hiraoka-Kanie M., Mitani K., Yamashita J.K. Convergence of Notch andβ-catenin signaling induces arterial fate in vascular progenitors. J. Cell Biol. 2010, 189:353-367.
17. Rochais F., Mesbah K., Kelly R.G. Signaling pathways controlling second heart field development. Circ. Res. 2009, 104:933-942.
18. Chien K.R., Domian I.J., Parker K.K. Cardiogenesis and the complex biology of regenerative cardiovascular medicine. Science 2008, 322:1494-1497.
19. Doetschman T.C., Eistetter H., Katz M., Schmidt W., Kemler R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 1985, 87:27-45.
20. Garry D.J., Olson E.N. A common progenitor at the heart of development. Cell 2006, 127:1101-1104.
21. Yan P., Nagasawa A., Uosaki H., Sugimoto A., Yamamizu K., Teranishi M., Matsuda H., Matsuoka S., Ikeda T., Komeda M., Sakata R., Yamashita J.K. Cyclosporin-A potently induces highly cardiogenic progenitors from embryonic stem cells. Biochem. Biophys. Res. Commun. 2009, 379:115-120.
22. + embryonic-stem-cell-derived population. Nature 2008, 453:524-529.
23. Bu L., Jiang X., Martin-Puig S., Caron L., Zhu S., Shao Y., Roberts D.J., Huang P.L., Domian I.J., Chien K.R. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 2009, 460:113-118.
24. Barile L., Messina E., Giacomello A., Marban E. Endogenous cardiac stem cells. Prog. Cardiovasc. Dis. 2007, 50:31-48.
25. Tateishi K., Ashihara E., Honsho S., Takehara M., Nomura T., Takahashi T., Ueyama T., Yamagishi M., Yaku H., Matsubara H., Oh H. Human cardiac stem cells exhibit mesenchymal features and are maintained through Akt/GSK-3β signaling. Biochem. Biophys. Res. Commun. 2007, 352:635-641.
26. Mauritz C., Schwanke K., Reppel M., Neef S., Katsirntaki K., Maier L.S., Nguemo F., Menke S., Haustein M., Hescheler J., Hasenfuss G., Martin U. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 2008, 118:507-517.
27. Schenke-Layland K., Rhodes K.E., Angelis E., Butylkova Y., Heydarkhan-Hagvall S., Gekas C., Zhang R., Goldhaber J.I., Mikkola H.K., Plath K., MacLellan W.R. Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineage. Stem Cells 2008, 26:1537-1546.
28. Zhang J., Wilson G.F., Soerens A.G., Koonce C.H., Yu J., Palecek S.P., Thomson J.A., Kamp T.J. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 2009, 104:e30-e41.
29. Kehat I., Khimovich L., Caspi O., Gepstein A., Shofti R., Arbel G., Huber I., Satin J., Itskovitz-Eldor J., Gepstein L. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol. 2004, 22:1282-1289.
30. Gnecchi M., Zhang Z., Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 2008, 103:1204-1219.
31. Johnston P.V., Sasano T., Mills K., Evers R., Lee S.T., Smith R.R., Lardo A.C., Lai S., Steenbergen C., Gerstenblith G., Lange R., Marban E. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation 2009, 120:1075-1083.
32. Shimizu T., Sekine H., Yamato M., Okano T. Cell sheet-based myocardial tissue engineering: new hope for damaged heart rescue. Curr. Pharm. Des. 2009, 15:2807-2814.
33. Miura K., Okada Y., Aoi T., Okada A., Takahashi K., Okita K., Nakagawa M., Koyanagi M., Tanabe K., Ohnuki M., Ogawa D., Ikeda E., Okano H., Yamanaka S. Variation in the safety of induced pluripotent stem cell lines. Nat. Biotechnol. 2009, 27:743-745.
34. Asai Y., Tada M., Otsuji T.G., Nakatsuji N. Combination of functional cardiomyocytes derived from human stem cells and a highly-efficient microelectrode array system: an ideal hybrid model assay for drug development. Curr. Stem Cell Res. Ther. 2010, (Electronic publication ahead of print).
35. Willems E., Bushway P.J., Mercola M. Natural and synthetic regulators of embryonic stem cell cardiogenesis. Pediatr. Cardiol. 2009, 30:635-642.
36. Vierbuchen T., Ostermeier A., Pang Z.P., Kokubu Y., Sudhof T.C., Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463:1035-1042.